Bloom43 uses supraphysiological preconditioning to assist patients prepare and safeguard their bodies before surgery.
Bloom43 has raised $4.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
Bloom43's investors include National Institute for Health and Care Research, THENA Capital, MedTech Innovator, Qubit Health Capital, TCP Health Ventures.
Bloom43 is headquartered in London, United Kingdom.
Bloom43 uses supraphysiological preconditioning to assist patients prepare and safeguard their bodies before surgery.
Bloom43 is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bloom43 — Funding & Investors." VCBacked, July 8, 2025, https://www.vcbacked.co/company/bloom43. Accessed July 22, 2026.
VCBacked. (2025). Bloom43 — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/bloom43
{{cite web |title=Bloom43 — Funding & Investors |url=https://www.vcbacked.co/company/bloom43 |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated